ACI’s 22nd Annual Paragraph IV Disputes: Elevate Your 2026 Hatch-Waxman Strategy

The American Conference Institute’s (ACI’s) Annual Paragraph IV Disputes Conference is scheduled to take place from April 21-22, 2026 at The Times Center, New York, NY.  Join the nation’s most respected forum for pharmaceutical patent litigation as it returns for its 22nd edition. This is the must-attend event where brand-name and generic drug stakeholders converge to shape litigation strategies, navigate regulatory shifts, and connect with the judiciary.

Don’t miss your chance to join the conversation that’s shaping the future of Hatch-Waxman litigation and:

• Benchmark with top ANDA litigators, in-house counsel, and regulators
• Stay ahead of landmark case developments and evolving PTAB practices
• Network with the leading minds in pharmaceutical IP law

Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be speaking at the conference in a session titled “FDA Focus: Round-up of Regulatory Developments for PIV Practitioners to Watch” along with Morgan Lewis LLP Partner Maarika Kimbrell.

FDA Law Blog is a conference media partner. As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA26.  You can access the conference brochure and sign up for the event here.  We look forward to seeing you at the conference.